In this regard, we found that ERβ-mediated inhibition of both tumor cell migration and invasion were significantly compromised by the Y36F mutation in MCF7 cells (Figure 1C–1D), thus implicating a role of the phosphotyrosine switch in multiple aspects of ERβ-mediated antitumor function. This evidence concerns the gene ESR2 and neoplasm.